The End of End Stage Renal Disease from Diabetes
Phil McFarlane, MD, Ph.D., FRCP(C)
Topics: Diabetes, Renal Disease
- Details
Objectives
Learning Objectives:
- Travel back in time to 2003 to view the establishment of the first pillars of renal protection in people with diabetes
- Examine recent advances in drug therapy for renal protection in diabetes
- View real world data to answer the question of whether old or new renal protection pillars have impacted on the need for dialysis amongst people with diabetes
Faculty
Phil McFarlane MD, Ph.D., FRCP(C)
Ontario Renal Network Medical Lead for Hemodialysis & Peritoneal Dialysis
Dr. Phil McFarlane is a clinical-investigator in the Division of Nephrology at St. Michael's Hospital in Toronto, and an assistant professor at the University of Toronto. At St. Michael’s he is the Medical Director of Home Dialysis and the Chief Nephrologist in the Live Kidney Donor Program. He is a member of the Diabetes Canada Clinical Practice Guidelines group, the Canadian Society of Nephrology guideline group, and the Hypertension Canada guideline group. He has completed his Ph.D. in health economics at the Institute for Medical Sciences at the University of Toronto. His areas of research interest include health economics and outcomes research. He is currently the Ontario Renal Network Provincial Medical Lead for Hemodialysis and Peritoneal Dialysis. He has published over 100 peer-reviewed manuscripts and three book chapters.